Coronavirus (COVID-19) Outcomes Registries in Immunocompromised Individuals Australia (CORIA)

Summary

CORIA is an observational cohort study of immunosuppressed populations who test positive for COVID-19. This includes people living with HIV, cancer, acquired immunodeficiency associated with other immunosuppressive therapy, primary immunodeficiency and recipients of a solid organ transplant. Participants will have routine clinical data collected with optional baseline collection and storage of a blood sample for storage . The study will be conducted in up to 30 sites within Australia.

Conditions

• HIV-1-infection
• Cancer
• Primary Immune Deficiency Disorder
• Immunosuppression Disorders
• COVID-19

Sponsors & Collaborators

• St Vincent's Hospital, Sydney

  collaborator OTHER

• Garvan Institute of Medical Research

  collaborator OTHER

• Westmead Hospital, Sydney, Australia

  collaborator UNKNOWN

• Blacktown Hospital, Sydney, Australia

  collaborator UNKNOWN

• Holdsworth House Medical Practice

  collaborator OTHER

• Royal North Shore Hospital

  collaborator OTHER

• Melanoma Institute Australia

  collaborator OTHER

• Prince of Wales Hospital, Sydney

  collaborator OTHER_GOV

• Gilead Sciences

  collaborator INDUSTRY

• Cancer Institute NSW

  collaborator UNKNOWN

• Cancer Council New South Wales

  collaborator OTHER

• Positive Life NSW

  collaborator UNKNOWN

• St George Hospital, Australia

  collaborator OTHER

• Liverpool Hospital, Sydney

  collaborator UNKNOWN

• Kirby Institute

  lead OTHER_GOV

Principal Investigators

• Mark Polizzotto, MD · Kirby Institute

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2020-05-11

Primary Completion

2022-04-27

Completion

2022-04-27

Countries

• Australia

Study Locations